The ARTIST Study and the Future of TAVR for Aortic Regurgitation

David Cohen moderates a panel on the ARTIST Trial, comparing TAVR with the Trilogy valve to SAVR in low/intermediate-risk aortic regurgitation patients. The discussion examines TAVR’s potential role and clinical impact in this underdiagnosed disease.